Company:AstraZeneca Pharmaceuticals (Ireland) DAC
Status:No Recent Update
Legal Category:Product subject to medical prescription which may not be renewed (A)
*Additional information is available within the SPC or upon request to the company
Discontinued Strength Notice
Bydureon 2 mg Powder and Solvent for Prolonged-Release Suspension for Injection in Pre-Filled Pen has been discontinued. It is expected that stock will be depleted by September 2022.